Loading clinical trials...
Loading clinical trials...
Blalock Taussig (BT) is a palliative procedure that preserves blood circulation to the lungs and alleviates cyanosis in patients with congenital heart diseases and reduced pulmonary blood flow. BT shu...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Universitas Sumatera Utara
Collaborators
NCT06711666 · Congenital Heart Disease, Cyanotic Congenital Heart Disease, and more
NCT04125550 · Cyanotic Congenital Heart Disease, Pediatric HD
NCT02712606 · Cyanotic Congenital Heart Disease
Universitas Sumatera Utara
Medan, North Sumatera
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions